I Abraham, K MacDonald, M Song, G Ciesielski, C Pacheco, C Lee, M Cholette, K Kinsey, P Speaks, C Hermans, H BriƩ, S Reel, P Van der Niepen, B Yee, S Vancayzeele
BACKGROUND AND AIMS: Obesity combined with hypertension places patients at greater risk for target-organ damage and cardiovascular disease. The purpose of this secondary analysis was to identify physician- and patient-levels determinants of blood pressure (BP) values and predictors of uncontrolled BP through subgroup analysis by body mass index (BMI). METHODS AND RESULTS: We conducted a subgroup analysis of 3006 patients with High-BMI (BMI >25 kg/m(2); n=2124) and Normal-BMI (BMI<25 kg/m(2); n=882) treated by 504 physicians and enrolled in PREVIEW, a Belgian prospective, multi-center, pharmaco-epidemiological study of 90-day second-line treatment with valsartan...
April 2013: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD